Samenvatting
The present invention is directed to the identification of a biomarker specifically located in the plasma membrane of pancreatic beta cells. Based on a set of specific features the biomarker is a unique candidate for imaging and targeting strategies to study the pancreatic beta cell mass in health and disease (T1D, T2D, pancreatic cancers, obesity, islet transplantation, beta cell regeneration).
| Originele taal-2 | English |
|---|---|
| Octrooinummer | WO2017182605 |
| Status | Published - 2017 |
Vingerafdruk
Duik in de onderzoeksthema's van 'A new biomarker expressed in pancreatic beta cells useful in imaging or targeting beta cells'. Samen vormen ze een unieke vingerafdruk.Projecten
- 1 Afgelopen
-
IWT710: Gerichte radionuclidentherapie van non-hodgkin lymfoom met anti-CD20 nanobodies
Devoogdt, N. (Administrative Promotor) & Krasniqi, A. (Mandataris)
1/01/15 → 31/12/18
Project: Fundamenteel
Citeer dit
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver